abstract |
The present invention provides a method and method for controlling mucin synthesis in controlling mucin overproduction associated with diseases such as asthma, chronic bronchitis, inflammatory lung disease, cystic fibrosis or chronic obstructive pulmonary disease (copd), including chronic respiratory infectious diseases. To therapeutic applications. |